Nexaph peptides represent a emerging frontier in drug development. These short strings of protein acids present remarkable promise for interacting with intractable pathways involved in various illnesses. Preliminary studies indicate these can achieve selective interaction and show promising ADME properties, creating paths to innovative medicines. F